Novo Nordisk
NVO
55,00 €
Share price
2.12%
Change (1 day)
-54.23%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
EPS for Novo Nordisk (NVO)
EPS in 2023 (TTM): 2,65 €
According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is 2,51 €. In 2022 the company made an earnings per share (EPS) of 1,91 € an increase over its 2021 EPS that were of 1,75 €.
EPS history for Novo Nordisk from 1996 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | 2,65 € | 39.16% |
| 2022 | 1,91 € | 9.01% |
| 2021 | 1,75 € | 15.08% |
| 2020 | 1,52 € | 14.83% |
| 2019 | 1,32 € | -1.68% |
| 2018 | 1,35 € | 4.96% |
| 2017 | 1,28 € | 31.08% |
| 2016 | 0,98 € | -10.33% |
| 2015 | 1,09 € | 13.91% |
| 2014 | 0,96 € | 4.03% |
| 2013 | 0,92 € | -28.81% |
| 2012 | 1,29 € | 108.9% |
| 2011 | 0,62 € | 25.59% |
| 2010 | 0,49 € | 35.01% |
| 2009 | 0,37 € | -9.17% |
| 2008 | 0,40 € | 61.35% |
| 2007 | 0,25 € | 28.96% |
| 2006 | 0,19 € | 25.63% |
| 2005 | 0,15 € | 4.17% |
| 2004 | 0,15 € | 13.55% |
| 2003 | 0,13 € | 36.87% |
| 2002 | 0,09500 € | -6.99% |
| 2001 | 0,10 € | 21.56% |
| 2000 | 0,08403 € | 55.81% |
| 1999 | 0,05393 € | 3.78% |
| 1998 | 0,05196 € | 12.15% |
| 1997 | 0,04634 € | 24.74% |
| 1996 | 0,03714 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | 1,63 € | -34.87% | 🇺🇸 USA |
 | 4,77 € | 90.12% | 🇺🇸 USA |
 | 3,49 € | 39.02% | 🇺🇸 USA |
 | 2,79 € | 11.36% | 🇫🇷 France |